BetterScholar BetterScholar

H. Fontaine

Hepatology, Gastroenterology, Journal of Hepatology, The Lancet, Clinical Cancer Research, Cancer Research, Blood Show more
12
Role
Title
Level Year L/R
🐜 FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest
8 auth. A. Vallet-Pichard, V. Mallet, B. Nalpas, V. Verkarre, A. Nalpas, V. Dhalluin-Venier, ... H. Fontaine, S. Pol 		11 2007
11
🐜
🐜 Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
39 auth. F. Carrat, H. Fontaine, C. Dorival, Mélanie Simony, A. Diallo, C. Hézode, V. Ledinghen, D. Larrey, G. Haour, J. Bronowicki, F. Zoulim, T. Asselah, P. Marcellin, D. Thabut, V. Leroy, ... A. Tran, F. Habersetzer, D. Samuel, D. Guyader, O. Chazouilleres, P. Mathurin, S. Metivier, L. Alric, G. Riachi, J. Gournay, A. Abergel, P. Calès, N. Ganne, V. Loustaud-Ratti, L. D’alteroche, X. Causse, Claire Geist, A. Minello, I. Rosa, M. Gelu-Simeon, I. Portal, F. Raffi, M. Bourliere, S. Pol 		8 2019
8
🐜
🐜 Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
47 auth. P. Nahon, Valérie Bourcier, Richard Layese, E. Audureau, C. Cagnot, P. Marcellin, D. Guyader, H. Fontaine, D. Larrey, V. de Lédinghen, D. Ouzan, F. Zoulim, D. Roulot, A. Tran, J. Bronowicki, ... J. Zarski, V. Leroy, G. Riachi, P. Calès, J. Péron, L. Alric, M. Bourliere, P. Mathurin, S. Dharancy, J. Blanc, A. Abergel, L. Serfaty, A. Mallat, J. Grangé, P. Attali, Y. Bacq, C. Wartelle, T. Dao, Y. Benhamou, C. Pilette, C. Silvain, C. Christidis, D. Capron, B. Bernard-Chabert, D. Zucman, V. Di Martino, V. Thibaut, D. Salmon, M. Ziol, A. Sutton, S. Pol, F. Roudot-thoraval 		8 2017
8
🐜
🐜 Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.
38 auth. C. Hézode, H. Fontaine, C. Dorival, D. Larrey, F. Zoulim, V. Canva, V. de Lédinghen, T. Poynard, D. Samuel, M. Bourliere, J. Zarski, J. Raabe, L. Alric, P. Marcellin, G. Riachi, ... P. Bernard, V. Loustaud-Ratti, S. Metivier, A. Tran, L. Serfaty, A. Abergel, X. Causse, V. Di Martino, D. Guyader, D. Lucidarme, V. Grando-Lemaire, P. Hillon, C. Féray, T. Dao, P. Cacoub, I. Rosa, P. Attali, V. Petrov-sanchez, Y. Barthe, J. Pawlotsky, S. Pol, F. Carrat, J. Bronowicki 		8 2013
8
🐜
🐜 Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3‐ and 6‐month periodicities
18 auth. J. Trinchet, C. Chaffaut, Valérie Bourcier, F. Degos, J. Henrion, H. Fontaine, D. Roulot, A. Mallat, S. Hillaire, P. Calès, ... I. Ollivier, J. Vinel, P. Mathurin, J. Bronowicki, V. Vilgrain, G. N’kontchou, M. Beaugrand, S. Chevret 		8 2011
8
🐜
🐜 Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
40 auth. C. Hézode, H. Fontaine, C. Dorival, F. Zoulim, D. Larrey, V. Canva, V. de Lédinghen, T. Poynard, D. Samuel, M. Bourliere, L. Alric, J. Raabe, J. Zarski, P. Marcellin, G. Riachi, ... P. Bernard, V. Loustaud-Ratti, O. Chazouilleres, A. Abergel, D. Guyader, S. Metivier, A. Tran, V. Di Martino, X. Causse, T. Dao, D. Lucidarme, I. Portal, P. Cacoub, J. Gournay, V. Grando-Lemaire, P. Hillon, P. Attali, T. Fontanges, I. Rosa, V. Petrov-sanchez, Y. Barthe, J. Pawlotsky, S. Pol, F. Carrat, J. Bronowicki 		8 2014
8
🐜
🐜 Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
45 auth. P. Nahon, Richard Layese, Valérie Bourcier, C. Cagnot, P. Marcellin, D. Guyader, S. Pol, D. Larrey, V. de Lédinghen, D. Ouzan, F. Zoulim, D. Roulot, A. Tran, J. Bronowicki, J. Zarski, ... G. Riachi, P. Calès, J. Péron, L. Alric, M. Bourliere, P. Mathurin, J. Blanc, A. Abergel, L. Serfaty, A. Mallat, J. Grangé, P. Attali, Y. Bacq, C. Wartelle, T. Dao, D. Thabut, C. Pilette, C. Silvain, C. Christidis, E. Nguyen-Khac, B. Bernard-Chabert, D. Zucman, V. Di Martino, A. Sutton, F. Roudot-thoraval, E. Audureau, H. Fontaine, V. Leroy, S. Dharancy, S. Hillaire 		7 2018
7
🐜
🐜 Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
19 auth. A. Desnoyer, D. Pospai, M. Lê, A. Gervais, A. Heurgue-berlot, A. Laradi, S. Harent, Adriana Pinto, D. Salmon, S. Hillaire, ... H. Fontaine, D. Zucman, A. Simonpoli, P. Muret, L. Larrouy, Brigitte Bernard Chabert, D. Descamps, Y. Yazdanpanah, G. Peytavin 		7 2016
7
🐜
🐬 Induction or expansion of T‐cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers
M. Mancini-Bourgine, H. Fontaine, D. Scott‐Algara, S. Pol, C. Bréchot, M. Michel 		7 2004
7
🐬
🐜 A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer
11 auth. Maïa Chanrion, V. Nègre, H. Fontaine, N. Salvetat, F. Bibeau, G. Grogan, ... L. Mauriac, D. Katsaros, F. Molina, C. Theillet, J. Darbon 		7 2008
7
🐜
🐜 Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
9 auth. M. Cuny, A. Kramar, F. Courjal, Vala Johannsdottir, B. Iacopetta, H. Fontaine, ... J. Grenier, S. Culine, C. Theillet 		7 2000
7
🐜
🐜 Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
25 auth. L. Arcaini, C. Besson, M. Frigeni, H. Fontaine, M. Goldaniga, M. Casato, M. Visentini, H. Torres, V. Loustaud-Ratti, J. Peveling-Oberhag, P. Fabris, R. Rossotti, F. Zaja, L. Rigacci, S. Rattotti, ... R. Bruno, M. Merli, C. Dorival, L. Alric, A. Jaccard, S. Pol, F. Carrat, V. Ferretti, C. Visco, O. Hermine 		7 2016
7
🐜